Symptomtext
medication error due to the extra dose of acthib given since it was concomitantly administered with pentacel with no reported adverse event; Initial information received on 15-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 months old male patient who experienced medication error due to the extra dose of acthib given since it was concomitantly administered with pentacel with no reported adverse event while receiving vaccine HIB (PRP/T) VACCINE [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, HIB VACCINE CONJ (TET TOX), PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, POLIO VACCINE INACT 3V (MRC 5), TETANUS VACCINE TOXOID (PENTACEL); PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13); and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ). On 15-Sep-2022, the patient received a 0.5 ml dose of suspect HIB (PRP/T) VACCINE once ( lot UJ583AB; expiry date: 15-Oct-2022) via unknown route in unknown administration site for immunization. On 15-SEP-2022 the patient reported a non-serious event medication error due to the extra dose of acthib given since it was concomitantly administered with pentacel with no reported adverse event (extra dose administered) following the administration of HIB (PRP/T) VACCINE. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event extra dose administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.